Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 7 | 2024 | 971 | 2.130 |
Why?
|
| Social Behavior | 3 | 2022 | 308 | 1.290 |
Why?
|
| Diet, High-Fat | 2 | 2022 | 244 | 1.200 |
Why?
|
| Autism Spectrum Disorder | 3 | 2024 | 377 | 1.130 |
Why?
|
| Axons | 4 | 2013 | 437 | 1.030 |
Why?
|
| Locomotion | 1 | 2021 | 88 | 0.720 |
Why?
|
| Probiotics | 1 | 2023 | 241 | 0.700 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2021 | 461 | 0.660 |
Why?
|
| Microbiota | 1 | 2023 | 545 | 0.560 |
Why?
|
| Dysbiosis | 3 | 2022 | 150 | 0.480 |
Why?
|
| Neuronal Plasticity | 2 | 2014 | 332 | 0.450 |
Why?
|
| Voltage-Gated Sodium Channel beta-4 Subunit | 1 | 2013 | 2 | 0.440 |
Why?
|
| Protein Biosynthesis | 2 | 2014 | 986 | 0.430 |
Why?
|
| Ranvier's Nodes | 1 | 2013 | 74 | 0.410 |
Why?
|
| I-kappa B Proteins | 1 | 2012 | 176 | 0.380 |
Why?
|
| Pregnancy | 6 | 2024 | 7916 | 0.370 |
Why?
|
| Nervous System | 1 | 2011 | 178 | 0.360 |
Why?
|
| Animals | 19 | 2024 | 61357 | 0.340 |
Why?
|
| Autistic Disorder | 2 | 2024 | 352 | 0.330 |
Why?
|
| Ankyrins | 4 | 2013 | 107 | 0.310 |
Why?
|
| Cognition Disorders | 1 | 2014 | 762 | 0.300 |
Why?
|
| Neurons | 4 | 2013 | 2450 | 0.300 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 515 | 0.280 |
Why?
|
| Mice | 14 | 2024 | 35421 | 0.270 |
Why?
|
| Action Potentials | 4 | 2018 | 588 | 0.270 |
Why?
|
| Nerve Tissue Proteins | 4 | 2021 | 1581 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 6 | 2024 | 7052 | 0.240 |
Why?
|
| Mental Disorders | 1 | 2011 | 878 | 0.230 |
Why?
|
| Dentate Gyrus | 1 | 2024 | 57 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2024 | 139 | 0.220 |
Why?
|
| Obesity | 1 | 2016 | 2895 | 0.220 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2024 | 132 | 0.220 |
Why?
|
| Learning | 2 | 2019 | 438 | 0.220 |
Why?
|
| Angelman Syndrome | 2 | 2013 | 77 | 0.200 |
Why?
|
| Mice, Transgenic | 4 | 2024 | 4202 | 0.190 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2021 | 17 | 0.190 |
Why?
|
| Primates | 1 | 2021 | 127 | 0.180 |
Why?
|
| Psychomotor Agitation | 1 | 2021 | 79 | 0.180 |
Why?
|
| Principal Component Analysis | 1 | 2021 | 221 | 0.180 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2021 | 122 | 0.170 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2021 | 168 | 0.170 |
Why?
|
| Buprenorphine | 1 | 2021 | 106 | 0.170 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2021 | 251 | 0.170 |
Why?
|
| Brain | 1 | 2013 | 4202 | 0.170 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2019 | 39 | 0.170 |
Why?
|
| Mice, Knockout | 3 | 2021 | 5692 | 0.160 |
Why?
|
| Disease Models, Animal | 7 | 2024 | 7317 | 0.160 |
Why?
|
| Hippocampus | 3 | 2014 | 926 | 0.160 |
Why?
|
| Social Behavior Disorders | 1 | 2018 | 12 | 0.160 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2021 | 262 | 0.150 |
Why?
|
| Seizures | 1 | 2024 | 996 | 0.150 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 464 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2013 | 2140 | 0.150 |
Why?
|
| Feces | 1 | 2021 | 851 | 0.140 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2021 | 307 | 0.140 |
Why?
|
| Female | 9 | 2024 | 148885 | 0.140 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 2192 | 0.140 |
Why?
|
| Housing, Animal | 1 | 2016 | 41 | 0.130 |
Why?
|
| Germ-Free Life | 1 | 2016 | 66 | 0.130 |
Why?
|
| Ventral Tegmental Area | 1 | 2016 | 51 | 0.130 |
Why?
|
| Bacteria | 1 | 2021 | 650 | 0.130 |
Why?
|
| Oxytocin | 1 | 2016 | 73 | 0.130 |
Why?
|
| Opioid-Related Disorders | 1 | 2021 | 420 | 0.130 |
Why?
|
| Memory | 1 | 2019 | 444 | 0.130 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2014 | 14 | 0.120 |
Why?
|
| Cells, Cultured | 2 | 2013 | 5657 | 0.120 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2014 | 90 | 0.110 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2014 | 64 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 1016 | 0.110 |
Why?
|
| Receptors, AMPA | 1 | 2014 | 82 | 0.110 |
Why?
|
| Rats | 2 | 2013 | 6397 | 0.110 |
Why?
|
| Voltage-Gated Sodium Channel beta Subunits | 1 | 2013 | 2 | 0.110 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 1 | 2013 | 14 | 0.110 |
Why?
|
| Diet | 1 | 2021 | 1470 | 0.110 |
Why?
|
| Myelin Basic Protein | 1 | 2013 | 95 | 0.110 |
Why?
|
| Male | 9 | 2024 | 128479 | 0.110 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2013 | 131 | 0.100 |
Why?
|
| COS Cells | 1 | 2013 | 417 | 0.100 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2012 | 137 | 0.100 |
Why?
|
| Cysteine | 1 | 2013 | 211 | 0.100 |
Why?
|
| Myelin Sheath | 1 | 2013 | 169 | 0.100 |
Why?
|
| Optical Imaging | 1 | 2013 | 158 | 0.100 |
Why?
|
| Ganglia, Spinal | 1 | 2013 | 251 | 0.090 |
Why?
|
| Signal Transduction | 3 | 2021 | 12042 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 687 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 5777 | 0.090 |
Why?
|
| Pyramidal Cells | 1 | 2011 | 172 | 0.090 |
Why?
|
| Cell Polarity | 1 | 2011 | 211 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 1098 | 0.090 |
Why?
|
| Membrane Potentials | 1 | 2011 | 443 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2021 | 2922 | 0.090 |
Why?
|
| Ion Channels | 1 | 2011 | 235 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 525 | 0.090 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 744 | 0.090 |
Why?
|
| Alleles | 1 | 2015 | 2598 | 0.080 |
Why?
|
| Phenotype | 2 | 2021 | 6502 | 0.070 |
Why?
|
| Transfection | 1 | 2013 | 3109 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2014 | 4907 | 0.070 |
Why?
|
| Risk Factors | 1 | 2024 | 17861 | 0.070 |
Why?
|
| Humans | 8 | 2024 | 270713 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 4105 | 0.060 |
Why?
|
| Models, Biological | 1 | 2014 | 3186 | 0.060 |
Why?
|
| Neuroprotection | 1 | 2024 | 22 | 0.060 |
Why?
|
| Mutation | 2 | 2015 | 15917 | 0.060 |
Why?
|
| Aging | 1 | 2011 | 1531 | 0.060 |
Why?
|
| Dendritic Spines | 1 | 2021 | 58 | 0.050 |
Why?
|
| Picrotoxin | 1 | 2018 | 17 | 0.040 |
Why?
|
| Receptors, Oxytocin | 1 | 2018 | 22 | 0.040 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2018 | 46 | 0.040 |
Why?
|
| Benzoxazines | 1 | 2018 | 26 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2018 | 103 | 0.040 |
Why?
|
| Language Development Disorders | 1 | 2019 | 167 | 0.040 |
Why?
|
| Capillary Permeability | 1 | 2018 | 116 | 0.040 |
Why?
|
| Smell | 1 | 2018 | 134 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2018 | 191 | 0.040 |
Why?
|
| Valproic Acid | 1 | 2018 | 272 | 0.040 |
Why?
|
| ras Proteins | 1 | 2021 | 804 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 884 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 277 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 821 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 491 | 0.030 |
Why?
|
| Gentamicins | 1 | 2015 | 110 | 0.030 |
Why?
|
| Drosophila | 1 | 2019 | 895 | 0.030 |
Why?
|
| Space Perception | 1 | 2014 | 75 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2015 | 266 | 0.030 |
Why?
|
| NAV1.6 Voltage-Gated Sodium Channel | 1 | 2013 | 16 | 0.030 |
Why?
|
| Piperidines | 1 | 2018 | 1099 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 651 | 0.030 |
Why?
|
| Transgenes | 1 | 2015 | 568 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 380 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2013 | 278 | 0.030 |
Why?
|
| Rett Syndrome | 1 | 2015 | 284 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2015 | 752 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 1467 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2015 | 1647 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 1535 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8603 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 3606 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 6344 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 32689 | 0.010 |
Why?
|
| Child | 1 | 2019 | 30560 | 0.010 |
Why?
|